CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-14 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,395 | $7.76 | $11K | 27,213 |
| 2023-07-14 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,813 | 16,877 | ||
| 2023-06-06 | Countouriotis Athena Director | Grant or award · Deferred Restricted Stock Unit | +51,955 | 51,955 | ||
| 2023-06-06 | MCPEAK MERRILL A Director | Grant or award · Deferred Restricted Stock Unit | +51,955 | 51,955 | ||
| 2023-06-06 | Maynard Ryan D Director | Grant or award · Deferred Restricted Stock Unit | +51,955 | 51,955 | ||
| 2023-06-06 | WEISER MICHAEL Director | Grant or award · Deferred Restricted Stock Unit | +51,955 | 51,955 | ||
| 2023-06-06 | Dukes Iain D. Director | Grant or award · Deferred Restricted Stock Unit | +103,911 | 103,911 | ||
| 2023-06-06 | YARNO WENDY L Director | Grant or award · Deferred Restricted Stock Unit | +12,988 | 12,988 | ||
| 2023-04-18 | YARNO WENDY L Director | Grant or award · Deferred Restricted Stock Unit | +74,823 | 74,823 | ||
| 2023-04-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +20,834 | 69,718 | ||
| 2023-04-14 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −8,851 | $5.64 | $50K | 60,867 |
| 2023-04-14 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −20,834 | 145,841 | ||
| 2023-04-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +2,812 | 30,930 | ||
| 2023-04-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −1,395 | $5.64 | $8K | 29,535 |
| 2023-04-14 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −2,812 | 19,690 | ||
| 2023-04-14 | BILINSKY IGOR Chief Operating Officer | Option exercise | +2,812 | 27,190 | ||
| 2023-04-14 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −1,395 | $5.64 | $8K | 25,795 |
| 2023-04-14 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −2,812 | 19,690 | ||
| 2023-03-02 | Vogt Frederick G See Remarks | Grant or award · Restricted Stock Units | +125,000 | 125,000 | ||
| 2023-03-02 | Vogt Frederick G See Remarks | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 |
Page 18 of 23 · 446 trades